MBX Capital

mbxcapital.com

Claymont, United States

Venture Capital

Active

Total investments

Average round size

13M

Portfolio companies

Lead investments

Follow on index

0.16

Stages of investment: Early Stage Venture
Areas of investment: BiotechnologyDrug DiscoveryPharmaceuticalsHealth CareWellnessMedical DeviceMedicalLife ScienceTherapeuticsDental

Investor highlights

Industry generalist: Yes
Industry focus: GeneralistHealthcareMedtechConsumer/Retail
Stage focus: Series ASeed
Geo focus: CanadaUnited States
Check size: 250K — 6M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Find investors

Investments analytics

Analytics

Total investments

Lead investments

Follow on index

0.16

Investments by industry

Health Care (22)
Biotechnology (15)
Medical (6)
Medical Device (4)
Life Science (4)

Show 34 more

Investments by region

United States (30)
India (1)
Canada (1)

Peak activity year

2021

Number of Unicorns

Number of Decacorns

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment: 6
Avg. valuation at time of investment: 67M
Group Appearance index: 0.84

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Upgrade

Latest deals

Company name	Deal date	Industry	Deal stage	Deal size	Location
SmileMD	13 Apr 2022	Health Care, Medical, Dental	Early Stage Venture	9M	United States, Ohio, Dublin
Vivodyne	22 Nov 2023	Biotechnology, Medical, Lifestyle	Seed	38M	United States, Pennsylvania, Philadelphia

Team

Discover decision-makers who fit your target profile.

View full list (2)

Gurdane Bhutani

Managing Partner

Gurdane Bhutani

Managing Partner

Interested in Decision Makers and their contacts?

Gain access to full profiles for all team members at MBX Capital.

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.